Evidence map›Paper›PMID 36709841›Full record

ArticleThe Journal of infection2023

The emergence of mumps after the COVID-19 pandemic in Pakistan: Time to consider MMR vaccination strategies.

Muhammad Suleman Rana, Muhammad Usman, Muhammad Masroor Alam, Muhammad Tahir, Aamer Ikram, Syed Sohail Zahoor Zaidi, Muqarrab Kashif, Massab Umair, Muhammad Anas, Nadeem Ullah and 1 more

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in The Journal of infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Muhammad Suleman RanaDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan. Electronic address: ranavirologist@gmail.com.
Muhammad UsmanDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Muhammad Masroor AlamDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Muhammad TahirFederal General Hospital, Chak Shahzad, Islamabad, Pakistan.
Aamer IkramDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Syed Sohail Zahoor ZaidiDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Muqarrab KashifWorld Health Organization, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Massab UmairDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Muhammad AnasDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Nadeem UllahDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
Muhammad SalmanDepartment of Virology, National Institute of Health, Park Road, Chak Shehzad, Islamabad 45500, Pakistan.
National Institute of Health · PK

Funding

World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19MeaslesMumpsRubellaAntibodies, ViralHumansInfantMeasles-Mumps-Rubella VaccinePakistanPandemicsVaccinationAntibodies, ViralMeasles-Mumps-Rubella Vaccine

Identifiers

PMID36709841
PMCPMC9897973
OpenAlexW4318069518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.